Abstract
Stem cell therapy uses of the ability of stem cells to differentiate into cells of other lineages, engraft into damaged tissues and promote their regeneration. However, the use of ESCs has been limited due to safety issues, which we have attempted to overcome by differentiating the cells before transplantation. In this study, we have induced the differentiation of KIND1 hESC line using a cocktail of growth factors present in SAGM. These differentiated cells were then transplanted into a bleomycin-induced mouse model of IPF, a degenerative lung disease with no permanent cure, to determine whether they could reduce the symptoms of the disease. We found that KIND1 hESCs, grown in SAGM for 48 h, predominantly differentiated into AQP5+ type-I alveolar epithelial cells, and a small fraction of SP-C+ AE-II cells. When transplanted into mice with IPF, these differentiated cells showed a significant alleviation of the disease symptoms, by engrafting into, and promoting regeneration of, the damaged tissue, thereby restoring the gas exchange capacity of the lungs. Thus, pre-differentiating hESCs into a specific lineage before transplantation could provide a safer and more economical therapy for degenerative diseases like IPF.
Similar content being viewed by others
Abbreviations
- SC:
-
Stem cell
- MSC:
-
Mesenchymal stem cells
- ESC:
-
Embryonic stem cell
- CD:
-
Cluster of differentiation
- ECM:
-
Extracellular matrix
- bFGF:
-
Basic fibroblast growth factor
- AE cells:
-
Alveolar epithelial cells
- AE-I:
-
Type I alveolar epithelial cell
- AE-II:
-
Type II alveolar epithelial cell
- AQP:
-
Aquaporin
- SP-C:
-
Surfactant protein-C
- SAGM:
-
Small airway epithelial cell growth medium
- IPF:
-
Idiopathic pulmonary fibrosis
- MTT:
-
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- Bleo:
-
Bleomycin
- PB:
-
Peripheral blood
- BALF:
-
Bronchoalveolar lavage fluid
- SEM:
-
Standard error of mean
References
Banerjee, E.R., M.A. Laflamme, T. Papayannopoulou, M. Kahn, C.E. Murry, and W.R. Henderson Jr. 2012. Human Embryonic Stem Cells Differentiated to Lung Lineage-Specific Cells Ameliorate Pulmonary Fibrosis in a Xenograft Transplant Mouse Model. PLoS ONE 7 (3): e33165.
Biehl, J.K., and B. Russell. 2009. Introduction to Stem Cell Therapy. Journal of Cardiovascular Nursing 24 (2): 98–105.
Burgess, R.J., M. Agathocleous, and S.J. Morrison. 2014. Metabolic regulation of stem cell function. Journal of Internal Medicine 276 (1): 12–24.
Chan, K.K.K., J. Zhang, N.Y. Chia, Y.S. Chan, H.S. Sim, K.S. Tan, S.K.W. Oh, H.H. Ng, and A.B.H. Choo. 2009. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells. Stem Cells. 279: 2114–2125.
Chen, F., and A. Fine. 2016. Stem Cells in Lung Injury and Repair. American Journal of Pathology 186 (10): 2544–2550.
Cheng, Z.J., and X.J. He. 2017. Anti-inflammatory effect of stem cells against spinal cord injury via regulating macrophage polarization. Journal of Neurorestoratology. 5: 31–38.
Dave, A., S. Kar, and E.R. Banerjee. 2018. Effect of CoCl2 or H2O2 pre-conditioned mesenchymal stem cells in a mouse model of pulmonary fibrosis. Biomedical Research and Therapy. 5 (4): 2208–2222.
Ding, J., D.Y. Takamoto, A. von Nahmen, M.M. Lipp, K.Y. Lee, A.J. Waring, and J.A. Zasadzinski. 2001. Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability. Biophysical Journal 80 (5): 2262–2272.
Flodby, P., C. Li, Y. Liu, H. Wang, M.E. Rieger, P. Minoo, E.D. Crandall, D.K. Ann, Z. Borok, and B. Zhou. 2017. Cell-specific expression of aquaporin-5 (Aqp5) in alveolar epithelium is directed by GATA6/Sp1 via histone acetylation. Science and Reports 7 (1): 3473.
Gao, L., X. Chen, Y. Zeng, Q. Li, T. Zou, S. Chen, Q. Wu, C. Fu, H. Xu, and Z.Q. Yin. 2016. Intermittent high oxygen influences the formation of neural retinal tissue from human embryonic stem cells. Science and Reports 6: 29944.
Gatie, M.I., and G.M. Kelly. 2018. Metabolic profile and differentiation potential of extraembryonic endoderm-like cells. Cell Death Discov. 4: 42.
Gilhodes, J.C., Y. Jule, S. Kreuz, B. Stierstorfer, D. Stiller, and L. Wollin. 2017. Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis. PLoS ONE 12 (1): e0170561.
Glasser, S.W., J.E. Baatz, and T.R. Korfhagen. 2011. Surfactant Protein-C in the Maintenance of Lung Integrity and Function. Journal of Allergy & Therapy S7: 001.
Hale, L.P., and M.L. Markert. 2004. Corticosteroids regulate epithelial cell differentiation and Hassall body formation in the human thymus. The Journal of Immunology 172 (1): 617–624.
Han H, Ziegler SF. 2013. Bronchoalveolar Lavage and Lung Tissue Digestion. Bio Protocol 3 (16): pii: e859.
Jouneau, S., B. Crestani, R. Thibault, M. Lederlin, L. Vernhet, C. Valenzuela, M. Wijsenbeek, M. Kreuter, W. Stansen, M. Quaresma, and V. Cottin. 2020. Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis. Respiratory Research 21 (1): 312.
Judge, J.L., D.J. Nagel, K.M. Owens, A. Rackow, R.P. Phipps, P.J. Sime, and R.M. Kottmann. 2018. Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol. PLoS ONE 13 (5): e0197936.
Juuti-Uusitalo, K., C. Delporte, F. Gregoire, J. Perret, H. Huhtala, V. Savolainen, S. Nymark, J. Hyttinen, H. Uusitalo, F. Willermain, and H. Skottman. 2013. Aquaporin expression and function in human pluripotent stem cell-derived retinal pigmented epithelial cells. Investigative Ophthalmology & Visual Science 54 (5): 3510–3519.
Keller, G. 2005. Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes & Development 19: 1129–1155.
Kim, S.N., J. Lee, H.S. Yang, J.W. Cho, S. Kwon, Y.B. Kim, J.D. Her, K.H. Cho, C.W. Song, and K. Lee. 2010. Dose-response Effects of Bleomycin on Inflammation and Pulmonary Fibrosis in Mice. Toxicological Research 26 (3): 217–222.
King, L.S., S. Nielsen, and P. Agre. 2000. Respiratory aquaporins in lung inflammation: The night is young. American Journal of Respiratory Cell and Molecular Biology 22 (1): 8–10.
Kondo, H., K. Miyoshi, S. Sakiyama, A. Tangoku, and T. Noma. 2015. Differential Regulation of Gene Expression of Alveolar Epithelial Cell Markers in Human Lung Adenocarcinoma-Derived A549 Clones. Stem Cells International. 2015: 165867.
Lawson, W.E., V.V. Polosukhin, G.T. Stathopoulos, O. Zoia, W. Han, K.B. Lane, B. Li, E.F. Donnelly, G.E. Holburn, K.G. Lewis, R.D. Collins, W.M. Hull, S.W. Glasser, J.A. Whitsett, and T.S. Blackwell. 2005. Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. American Journal of Pathology 167 (5): 1267–1277.
Lin, L., and L. Du. 2018. The role of secreted factors in stem cells-mediated immune regulation. Cellular Immunology 326: 24–32.
Lynch JP 3rd, Standiford TJ, Rolfe MW, Kunkel SL, Strieter RM. 1992. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. The American Review of Respiratory Disease 145 (6): 1433–149.
Mahla, R.S. 2016. Stem cells application in regenerative medicine and disease therapeutics. International Journal of Cell Biology 2016 (7): 1–24.
Maraldi, T., C. Angeloni, C. Prata, and S. Hrelia. 2021. NADPH Oxidases: Redox Regulators of Stem Cell Fate and Function. Antioxidants (basel). 10 (6): 973.
McElroy, M.C., and M. Kasper. 2004. The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. European Respiratory Journal 24 (4): 664–673.
Meleshina, A.V., V.V. Dudenkova, M.V. Shirmanova, V.I. Shcheslavskiy, W. Becker, A.S. Bystrova, E.I. Cherkasova, and E.V. Zagaynova. 2016. Probing metabolic states of differentiating stem cells using two-photon FLIM. Science and Reports 6: 21853.
Merten, M.D., J.M. Tournier, Y. Meckler, and C. Figarella. 1993. Epinephrine promotes growth and differentiation of human tracheal gland cells in culture. American Journal of Respiratory Cell and Molecular Biology 9 (2): 172–178.
Milara, J., G. Hernandez, B. Ballester, A. Morell, I. Roger, P. Montero, J. Escrivá, J.M. Lloris, M. Molina-Molina, E. Morcillo, and J. Cortijo. 2018. The JAK2 pathway is activated in idiopathic pulmonary fibrosis. Respiratory Research 19 (1): 24.
Min, K.A., G.R. Rosania, and M.C. Shin. 2016. Human Airway Primary Epithelial Cells Show Distinct Architectures on Membrane Supports Under Different Culture Conditions. Cell Biochemistry and Biophysics 74 (2): 191–203.
Mitra, S., A. Dave, and E.R. Banerjee. 2018. Current Trends in Therapeutic Uses of Pluripotent Stem Cells from Various Sources. The Journal of Stem Cell Research & Therapy 8 (1): 410.
Molina, S.A., H.K. Moriarty, D.T. Infield, B.R. Imhoff, R.J. Vance, A.H. Kim, J.M. Hansen, W.R. Hunt, M. Koval, and N.A. McCarty. 2017. Insulin signaling via the PI3-kinase/Akt pathway regulates airway glucose uptake and barrier function in a CFTR-dependent manner. American Journal of Physiology. Lung Cellular and Molecular Physiology 312 (5): L688–L702.
Moore, B.B., W.E. Lawson, T.D. Oury, T.H. Sisson, K. Raghavendran, and C.M. Hogaboam. 2013. Animal Models of Fibrotic Lung Disease. American Journal of Respiratory Cell and Molecular Biology 49 (2): 167–179.
Mulugeta, S., and M.F. Beers. 2006. Surfactant protein C: Its unique properties and emerging immunomodulatory role in the lung. Microbes and Infection 8 (8): 2317–2323.
Nagvenkar, P., P. Pethe, H. Pawani, J. Telang, N. Kumar, I. Hinduja, K. Zaveri, and D. Bhartiya. 2011. Evaluating differentiation propensity of in-house derived human embryonic stem cell lines KIND-1 and KIND-2. In Vitro Cellular and Developmental Biology. IAnimal 47 (5–6): 406–419.
Nogee, L.M. 2002. Abnormal expression of surfactant protein C and lung disease. American Journal of Respiratory Cell and Molecular Biology 26 (6): 641–644.
Pethe, P., P. Nagvenkar, and D. Bhartiya. 2014. Polycomb group protein expression during differentiation of human embryonic stem cells into pancreatic lineage in vitro. BMC Cell Biology 15: 18.
Pugashetti, J., J. Graham, N. Boctor, C. Mendez, E. Foster, M. Juarez, R. Harper, B. Morrissey, M. Kadoch, and J.M. Oldham. 2018. Weight loss as a predictor of mortality in patients with interstitial lung disease. European Respiratory Journal 52 (3): 1801289.
Pursani, V., S. Kapoor, S.M. Metkari, P. Nair, and D. Bhartiya. 2017. Evaluating KIND1 human embryonic stem cell-derived pancreatic progenitors to ameliorate streptozotocin-induced diabetes in mice. Indian Journal of Medical Research 146 (2): 244–254.
Rodríguez-Rodríguez, P., S.M. Arribas, A.L.L. de Pablo, M.C. González, F. Abderrahim, and L. Condezo-Hoyos. 2013. A simple dot-blot-Sirius red-based assay for collagen quantification. Analytical and Bioanalytical Chemistry 405 (21): 6863–6871.
Romito, A., and G. Cobellis. 2016. Pluripotent Stem Cells: Current Understanding and Future Directions. Stem Cells International 2016: 9451492.
Ruta, V.M., A.M. Man, T.G. Alexescu, N.S. Motoc, S. Tarmure, R.A. Ungur, D.A. Todea, S.C. Coste, D. Valean, and M.C. Pop. 2020. Neutrophil-To-Lymphocyte Ratio and Systemic Immune-Inflammation Index-Biomarkers in Interstitial Lung Disease. Medicina (kaunas, Lithuania) 56 (8): 381.
Schilders, K.A., E. Eenjes, S. van Riet, A.A. Poot, D. Stamatialis, R. Truckenmüller, P.S. Hiemstra, and R.J. Rottier. 2016. Regeneration of the lung: Lung stem cells and the development of lung mimicking devices. Respiratory Research 17: 44.
Sehlmeyer, K., J. Ruwisch, N. Roldan, and E. Lopez-Rodriguez. 2020. Alveolar Dynamics and Beyond—The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis. Frontiers in Physiology 11: 386.
Serrano-Mollar, A. 2018. Cell Therapy in Idiopathic Pulmonary Fibrosis. Medical Sciences (Basel). 6 (3): 64.
Sgalla, G., B. Iovene, M. Calvello, M. Ori, F. Varone, and L. Richeldi. 2018. Idiopathic pulmonary fibrosis: Pathogenesis and management. Respiratory Research 19 (1): 32.
Shyh-Chang, N., and H.H. Ng. 2017. The metabolic programming of stem cells. Genes & Development 31 (4): 336–346.
Stavridis, M.P., B.J. Collins, and K.G. Storey. 2010. Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation. Development 137 (6): 881–890.
Tashiro, J., G.A. Rubio, A.H. Limper, K. Williams, S.J. Elliot, I. Ninou, V. Aidinis, A. Tzouvelekis, and M.K. Glassberg. 2017. Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis. Frontiers of Medicine (Lausanne). 4: 118.
Tuch, B.E. 2006. Stem cells–-a clinical update. Australian Family Physician 35: 719–721.
Tzouvelekis, A., R. Toonkel, T. Karampitsakos, K. Medapalli, I. Ninou, V. Aidinis, D. Bouros, and M.K. Glassberg. 2018. Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis. Front Med (Lausanne). 5: 142.
Wang, W.J., B. Liao, M. Zeng, C. Zhu, and X.M. Fan. 2009. The effects of aerosolized STAT1 antisense oligodeoxynucleotides on rat pulmonary fibrosis. Cellular & Molecular Immunology 6 (1): 51–59.
Wittekindt, O.H., and P. Dietl. 2019. Aquaporins in the lung. Pflugers Archives. European Journal of Physiology 471 (4): 519–532.
Yadav, E., N. Yadav, A. Hus, and J.S. Yadav. 2020. Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications. Respiratory Medicine 174: 106193.
Zaidman, N.A., A. Panoskaltsis-Mortari, and S.M. O’Grady. 2016. Differentiation of human bronchial epithelial cells: Role of hydrocortisone in development of ion transport pathways involved in mucociliary clearance. American Journal of Physiology. Cell Physiology 311 (2): C225–C236.
Zhao, W., X. Ji, F. Zhang, L. Li, and L. Ma. 2012. Embryonic Stem Cell Markers. Molecules 17 (6): 6196–6246.
Zinellu, A., P. Paliogiannis, E. Sotgiu, S. Mellino, A.A. Mangoni, E. Zinellu, S. Negri, C. Collu, G. Pintus, A. Serra, A.M. Pistuddi, C. Carru, P. Pirina, and A.G. Fois. 2020. Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis. Lung 198 (5): 821–827.
Acknowledgements
We are greatly obliged to Dr. Sujata Mohanty (Professor, Centre of Excellence for Stem Cell Research, All India Institute of Medical Sciences, New Delhi, India) and her research fellows for their endless help in establishing the cell line and in allowing us to perform some of the experiments in their laboratory. We also acknowledge the Indian Institute of Chemical Biology (IICB), Kolkata, for allowing us to use the BD LSRFortessa. We would like to acknowledge the Indian Council of Medical Research (ICMR), UGC-UPE-II and UGC-DRS-SAP-Phase II for providing research support for this work, DST-FIST-Phase III for departmental instruments, and DST-PURSE-Phase II for departmental infrastructural support. We acknowledge the University Grants Commission (UGC), New Delhi, for providing fellowship to SM.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Conceptualization and supervision was done by ERB. Study design, material preparation, data collection and analysis were performed by SM. The first draft of the manuscript was written by SM and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest among the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mitra, S., Banerjee, E.R. Pre-Differentiation of KIND1 Human Embryonic Stem Cell Line into Type I Alveolar Epithelial Cells Alleviates Symptoms of Idiopathic Pulmonary Fibrosis in Mice. Proc Zool Soc 76, 73–90 (2023). https://doi.org/10.1007/s12595-023-00469-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12595-023-00469-2